| 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (NCT01940926) | Peking Union Medical College Hospital | 2012-02-01 |
| A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis (NCT01562327) | Hoffmann-La Roche | 2012-02-01 |
| An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis (NCT01543503) | Hoffmann-La Roche | 2012-02-01 |
| Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) (NCT01352858) | Newcastle University | 2012-02-01 |
| An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis (NCT01613027) | Hoffmann-La Roche | 2012-02-01 |
| The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis (NCT01533714) | UCB BIOSCIENCES, Inc. | 2012-01-26 |
| Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis (NCT02922192) | Biologics & Biosimilars Collective Intelligence Consortium | 2012-01-01 |
| A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia (NCT02564770) | Hoffmann-La Roche | 2012-01-01 |
| A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (NCT01519791) | UCB Pharma SA | 2012-01-01 |
| Gender Solutions Natural Knee Post-Market Study (NCT01463566) | Zimmer Biomet | 2012-01-01 |
| Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease (NCT04952896) | Peking University Third Hospital | 2012-01-01 |
| Long Term Extension Study For SPM-005 Participants (NCT01552538) | SetPoint Medical Corporation | 2012-01-01 |
| Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis (NCT01417455) | Instituto de Medicina Molecular João Lobo Antunes | 2012-01-01 |
| Safety of Zostavax Vaccination in Rheumatoid Arthritis (NCT01506661) | Oklahoma Medical Research Foundation | 2012-01-01 |
| Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns (NCT01511926) | AstraZeneca | 2012-01-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids (NCT01564901) | Hoffmann-La Roche | 2012-01-01 |
| A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab (NCT01502423) | AbbVie (prior sponsor, Abbott) | 2012-01-01 |
| Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (NCT01526434) | UCB Pharma SA | 2012-01-01 |
| Rituximab-induced Pulmonary Function Changes (NCT01632124) | University of Zurich | 2012-01-01 |
| A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (NCT01521923) | UCB Pharma | 2012-01-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (NCT01474291) | Hoffmann-La Roche | 2012-01-01 |
| A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs) (NCT01511003) | Astellas Pharma Inc | 2011-12-05 |
| Prediction of Methotrexate Response - A Pilot Study (NCT01726959) | Wake Forest University Health Sciences | 2011-12-01 |
| Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s) (NCT01489384) | Pope Research Corporation | 2011-12-01 |
| Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate (NCT01500278) | UCB Pharma SA | 2011-12-01 |
| A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea (NCT01294722) | Janssen Korea, Ltd., Korea | 2011-12-01 |
| Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects (NCT01499732) | Orrin M Troum, M.D. and Medical Associates | 2011-12-01 |
| Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis (NCT01443364) | UCB Italy s.p.a. | 2011-12-01 |
| Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis (NCT01752335) | Hospital Universitario de Canarias | 2011-12-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF (NCT01326962) | Hoffmann-La Roche | 2011-11-30 |
| Vascular Occlusion and Rheumatoid Arthritis (NCT01483157) | University of Sao Paulo | 2011-11-01 |
| Fatigue in Rheumatoid Arthritis - Longitudinal Study (NCT01697202) | Göteborg University | 2011-11-01 |
| An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy (NCT01592292) | Hoffmann-La Roche | 2011-11-01 |
| Rheumatoid Arthritis Through Education and US Study (RAEUS) (NCT02351401) | National University Hospital, Singapore | 2011-11-01 |
| Effect of Smoking on Pain and Atherosclerosis in Patients With Rheumatoid Arthritis (NCT03449589) | Vastra Gotaland Region | 2011-11-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis (NCT01251120) | Hoffmann-La Roche | 2011-11-01 |
| A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment (NCT01468077) | Hoffmann-La Roche | 2011-11-01 |
| Study of the Efficacy and Safety of Cholecalciferol Supplementation on the Activity of Rheumatoid Arthritis in Patients With Vitamin D Deficiency (NCT02243800) | University Hospital, Clermont-Ferrand | 2011-11-01 |
| Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC) (NCT03274141) | Bristol-Myers Squibb | 2011-10-31 |
| Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis (NCT01451203) | Astellas Pharma Inc | 2011-10-11 |
| RHYTHM (Formerly Escape II Myocardium) (NCT01548768) | Columbia University | 2011-10-10 |
| Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis (NCT01954381) | Assistance Publique Hopitaux De Marseille | 2011-10-01 |
| Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy (NCT01463059) | UCB Japan Co. Ltd. | 2011-10-01 |
| Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb (NCT01439204) | Bristol-Myers Squibb | 2011-10-01 |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent (NCT01641952) | Hoffmann-La Roche | 2011-10-01 |
| Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement (NCT01292616) | University of Zurich | 2011-10-01 |
| Metal Ions in Ceramic on Metal Total Hip Arthroplasty (NCT01437124) | Hussain Kazi | 2011-10-01 |
| Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography (NCT01476956) | CARE ARTHRITIS LTD. | 2011-10-01 |
| Novel Form of Acquired Long QT Syndrome (NCT04169100) | Narrows Institute for Biomedical Research | 2011-09-28 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01245439) | Hoffmann-La Roche | 2011-09-01 |
| A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo (NCT01359150) | Pfizer | 2011-09-01 |
| A Nutritional Intervention for Arthritis (NCT01544101) | Physicians Committee for Responsible Medicine | 2011-09-01 |
| Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? (NCT02164214) | Assistance Publique Hopitaux De Marseille | 2011-09-01 |
| Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) (NCT01350804) | Novartis Pharmaceuticals | 2011-09-01 |
| A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis (NCT01462162) | Hoffmann-La Roche | 2011-09-01 |
| Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients (NCT02076659) | Philogen S.p.A. | 2011-09-01 |
| Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis (NCT01404585) | Bristol-Myers Squibb | 2011-09-01 |
| A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis (NCT01417052) | Lexicon Pharmaceuticals | 2011-09-01 |
| Web-based Support to Manage Arthritis Pain (NCT01463189) | Inflexxion, Inc. | 2011-09-01 |
| An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) (NCT01667458) | Hoffmann-La Roche | 2011-09-01 |
| Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis (NCT02008266) | Hoffmann-La Roche | 2011-09-01 |
| Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP) (NCT01383421) | AbbVie (prior sponsor, Abbott) | 2011-09-01 |
| More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR) (NCT01564147) | Nantes University Hospital | 2011-09-01 |
| A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis (NCT01430507) | Glenmark Pharmaceuticals Ltd. India | 2011-09-01 |
| Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) (NCT01374971) | Nathan Wei, MD, FACP, FACR: | 2011-09-01 |
| Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents (NCT01377012) | Novartis Pharmaceuticals | 2011-08-30 |
| A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors (NCT01331837) | Hoffmann-La Roche | 2011-08-02 |
| SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. (NCT01295151) | Julia Brown | 2011-08-01 |
| Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD) (NCT01577264) | UCB Pharma | 2011-08-01 |
| Study of Venous Endothelial Cells in Rheumatoid Arthritis (NCT02468986) | University of Texas Southwestern Medical Center | 2011-08-01 |
| A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia (NCT01387789) | AbbVie (prior sponsor, Abbott) | 2011-08-01 |
| VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis (NCT01390545) | Takeda | 2011-08-01 |
| A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants (NCT01442545) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-08-01 |
| An Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis (NCT02658370) | Eugen Feist | 2011-08-01 |
| Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis (NCT01414101) | Ionis Pharmaceuticals, Inc. | 2011-08-01 |
| A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients (NCT01426789) | Novartis Pharmaceuticals | 2011-08-01 |
| Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (NCT01400516) | Brigham and Women's Hospital | 2011-08-01 |
| A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis (NCT01382940) | Hoffmann-La Roche | 2011-07-26 |
| Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis (NCT01552941) | SetPoint Medical Corporation | 2011-07-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (NCT01388309) | Hoffmann-La Roche | 2011-07-01 |
| Very Early Versus Delayed Etanercept in Patients With RA (NCT02433184) | University of Leeds | 2011-07-01 |
| A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) (NCT01390441) | Merck Sharp & Dohme LLC | 2011-07-01 |
| Progressive Resistance Exercise in Rheumatoid Arthritis (NCT02219022) | Federal University of São Paulo | 2011-07-01 |
| Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers (NCT01405118) | Pfizer | 2011-06-01 |
| A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants (NCT01450982) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-06-01 |
| An Open Label Study for Participants With Rheumatoid Arthritis (NCT01215942) | Eli Lilly and Company | 2011-06-01 |
| Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice (NCT01692899) | Pfizer | 2011-06-01 |
| Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment) (NCT01346488) | AbbVie (prior sponsor, Abbott) | 2011-06-01 |
| A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis (NCT01369745) | Zalicus | 2011-06-01 |
| Orofacial Evaluation in Women With Rheumatoid Arthritis (NCT01616641) | Federal University of São Paulo | 2011-06-01 |
| Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients (NCT01384422) | Lakefront Biotherapeutics NV | 2011-06-01 |
| Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients (NCT01351480) | Arthritis & Rheumatic Disease Specialties Research | 2011-06-01 |
| Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate (NCT01373151) | CSL Behring | 2011-06-01 |
| A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor (NCT01283971) | Hoffmann-La Roche | 2011-05-01 |
| Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis (NCT01262118) | Pfizer | 2011-05-01 |
| Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis (NCT01404429) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-05-01 |
| An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) (NCT01394276) | Hoffmann-La Roche | 2011-05-01 |
| Effect of a Thin Customized Insole in RA (NCT02964156) | Revmatismesykehuset AS | 2011-05-01 |
| REstore Working Ability in RheumatoiD Arthritis (NCT01405326) | The Rheumatological Center of Helsinki | 2011-05-01 |
| Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate (NCT01329991) | Plexxikon | 2011-05-01 |